
Owkin, Leading AI-Biotech Innovator, Expands Cutting-Edge AI to Germany, Austria, and Switzerland to Advance Research
Owkin, the pioneering AI-biotech unicorn specializing in AI-driven precision drug discovery, development, and diagnostics, has launched its expansion into the DACH region (Germany, Austria, and Switzerland). This expansion follows strategic partnerships with nine leading institutions in the region, including Charité…













